PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Clinical Neuroscience and Therapeutics, Hiroshima University, Graduate School of Biomedical and Health Sciences, Japan; Epilepsy Center, Hiroshima University Hospital, Japan. Electronic address: s-neshige@hiroshima-u.ac.jp.\', \'Department of Clinical Neuroscience and Therapeutics, Hiroshima University, Graduate School of Biomedical and Health Sciences, Japan.\', \'Epilepsy Center, Hiroshima University Hospital, Japan; Department of Neurosurgery, Hiroshima University, Graduate School of Biomedical and Health Sciences, Japan.\', \'Department of Clinical Neuroscience and Therapeutics, Hiroshima University, Graduate School of Biomedical and Health Sciences, Japan; Epilepsy Center, Hiroshima University Hospital, Japan.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0022-510X(21)02802-110.1016/j.jns.2021.120100
?:doi
?:hasPublicationType
?:journal
  • Journal of the neurological sciences
is ?:pmid of
?:pmid
?:pmid
  • 34952346
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.002
?:rankingScore_hIndex
  • 120
?:title
  • A longitudinal seizure outcome following the COVID-19 pandemic in 2020 and 2021: Transient exacerbation or sustainable mitigation.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all